Two Sigma Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,100
Closed -$325K 1571
2024
Q3
$325K Sell
3,100
-1,600
-34% -$187K 0.01% 1665
2024
Q2
$668K Sell
4,700
-9,700
-67% -$1.12M 0.01% 1329
2024
Q1
$1.61M Buy
14,400
+7,100
+97% +$846K 0.02% 874
2023
Q4
$947K Buy
7,300
+1,900
+35% +$262K 0.01% 1080
2023
Q3
$880K Sell
5,400
-8,800
-62% -$1.55M 0.01% 1132
2023
Q2
$2.6M Buy
14,200
+8,900
+168% +$1.28M 0.04% 498
2023
Q1
$706K Buy
+5,300
New +$623K 0.01% 1038

Other funds holding ACLS

Two Sigma Securities's ACLS Position: Q1 2026 in Review

Two Sigma Securities sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 9,333 shares — an estimated $750K sold.

Two Sigma Securities first reported a position in ACLS in Q3 2023 and held it in 4 quarters. The position peaked at $750K in Q4 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Two Sigma Securities reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 9,333 Axcelis shares in Q1 2026, an estimated $750K.
  • Two Sigma Securities first reported a position in Axcelis in Q3 2023 and held it in 4 quarters.
  • Two Sigma Securities's Axcelis position peaked at $750K in Q4 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.